Yurtdas, MustafaYaylali, Yalin TolgaAladag, NesimOzdemir, MahmutAtay, Memis Hilmi2025-05-102025-05-1020141687-96271687-963510.1155/2014/190149https://doi.org/10.1155/2014/190149https://hdl.handle.net/20.500.14720/10688Aladag, Nesim/0000-0003-2346-1152; Yurtdas, Mustafa/0000-0002-0516-9206Tirofiban, a specific glycoprotein IIb/IIIa inhibitor, may cause extensive thrombocytopenia with an incidence of 0.2% to 0.5%. We report the case of a 50-year-oldman who developed thrombocytopenia after tirofiban use (both intracoronary and peripheral) over hours and the successful management of this complication after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.eninfo:eu-repo/semantics/openAccessArticle2014N/AQ224715904WOS:000215268900015